Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)
21.27
+0.31 (1.48%)
Apr 1, 2025, 2:45 PM CST
SHA:600129 Revenue
In the year 2024, Chongqing Taiji Industry(Group) Co.,Ltd had annual revenue of 12.39B CNY, down -20.72%. Chongqing Taiji Industry(Group) Co.,Ltd had revenue of 1.95B in the quarter ending December 31, 2024, a decrease of -43.25%.
Revenue
12.39B
Revenue Growth
-20.72%
P/S Ratio
0.90
Revenue / Employee
983.88K
Employees
12,589
Market Cap
11.67B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12.39B | -3.24B | -20.72% |
Dec 31, 2023 | 15.62B | 1.50B | 10.58% |
Dec 31, 2022 | 14.13B | 1.98B | 16.28% |
Dec 31, 2021 | 12.15B | 941.63M | 8.40% |
Dec 31, 2020 | 11.21B | -435.28M | -3.74% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |